←
Pharmaceutical Science at FIP784 posts
Pharmaceutical Science at FIP avatar

Pharmaceutical Science at FIP

@FIP_BPS

FIP’s Board of Pharmaceutical Sciences sharing the latest news and views with scientists around the world.

◷ Joined May 2019▧ 495 Photos and videos
Pharmaceutical Science at FIP avatar
Pharmaceutical Science at FIP@FIP_BPS·3 Nov 2025

Congrats to Bushra Haque for winning the YSA Best Poster at Copenhagen Congress! Her work explores culturally safe care transitions for First Nations patients👏.

Post attachment
Pharmaceutical Science at FIP avatar
Pharmaceutical Science at FIP@FIP_BPS·3 Oct 2025

Congrats to David Hinolan for his standout YSA Rapid Fire talk at the Copenhagen Congress: “FePt-incorporated MOF nanoparticles for drug delivery & sonodynamic therapy”!👏

Post attachment
Pharmaceutical Science at FIP avatar
Pharmaceutical Science at FIP@FIP_BPS·6 Aug 2025

We hope to see you at the FIP congress in Copenhagen in September! On 2 September, there will be a Focus on Science, with topics include precision medicine, AI in drug discovery, regulation, and GLP-1 agonists. Check out the programme and register here: copenhagen2025.fip.org

Post attachment
Pharmaceutical Science at FIP avatar
Pharmaceutical Science at FIP@FIP_BPS·16 Jul 2025

In this perspective from Maria Laura Bolognesi and team, the UN Sustainable development goals are placed in the context of medicinal chemistry and outlines how we can “turn words into actions”. pubs.acs.org/doi/10.1021/acs…

FIP avatar
⟳ Pharmaceutical Science at FIP retweeted
FIP@FIP_org·24 Feb 2025

Giovanni Pauletti, @FIP_BPS chair, shares his vision for strengthening pharmaceutical sciences & empowering the next generation of scientists to drive innovation.📖Read the full interview in this month’s International Pharmacy Journal (IPJ): fip.org/publications?item=91….

Post attachment
Pharmaceutical Science at FIP avatar
Pharmaceutical Science at FIP@FIP_BPS·30 Jan 2025

A blood-first assay screening trial found entrectinib equally effective in advanced/metastatic non-small cell lung cancer patients diagnosed by liquid biopsy or tissue testing, achieving an 81.5% response rate. More in @NatureMedicine: nature.com/articles/s41591-0…